By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Алзер-Эйч

CheckAnalogsCompareThe price unknown
Can't order it
  1. Active ingredients
  2. Pharmacological Group
  3. Analogs
  4. ATX code
  5. Indications for use
  6. Used in the treatment of
  7. Contraindications of the components
  8. Side effects of the components
  9. Manufacturers of the drug

Active ingredients

Pharmacological Group

M-, n-Cholinomimetics, pm anticholinesterase agents || Anticholinesterase agents

Analogs

Complete analogs for the substance

ATX code

 N06DA02 Донепезил.

Indications for use

 Список кодов МКБ-10.
 • F00 Деменция при болезни Альцгеймера (G30+).
 • G30 Болезнь Альцгеймера.

Used in the treatment of

Contraindications of the components

Противопоказания Donepezil.

 Гиперчувствительность (в тч к производным пиперидина).

Использование препарата Donepezil при кормлении грудью.

 Категория действия на плод по FDA. с.

Side effects of the components

Побочные эффекты Donepezil.

 Со стороны органов ЖКТ. Диспептические явления (тошнота, рвота, диарея).
 Со стороны нервной системы и органов чувств. Головная боль. головокружение. повышенная утомляемость. инсомния. судороги. обморок.
 Со стороны сердечно-сосудистой системы и крови (кроветворение, гемостаз): брадикардия, нарушения синоатриальной и AV проводимости.
 Прочие. Повышение уровня креатинфосфокиназы.

Manufacturers (or distributors) of the drug

МАКИЗ-ФАРМА ООО
Hetero Labs Limited
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.